Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-22-001633
Filing Date
2022-02-14
Accepted
2022-02-14 17:06:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9181468_13g-a.htm SC 13G/A 106481
  Complete submission text file 0000919574-22-001633.txt   108137
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Subject) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79364 | Film No.: 22634450
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 MARSHALL STREET SUITE 310 SOUTH NORWALK CT 06854
Business Address 20 MARSHALL STREET SUITE 310 SOUTH NORWALK CT 06854 203-956-7953
DISCOVERY CAPITAL MANAGEMENT, LLC / CT (Filed by) CIK: 0001389507 (see all company filings)

EIN.: 000000000 | State of Incorp.: CT
Type: SC 13G/A